Latest Articles

Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.

Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome influences the effectiveness of cancer treatments, particularly immunotherapy and chemotherapy.

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.

Explore the future of precision medicine cancer therapy. Understand personalized treatment strategies and innovations shaping oncology care.

This article examines how physical activity and exercise influence cancer prevention, mitigate treatment-related side effects, enhance quality of life and impact overall mortality in oncology patients.

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based approaches, highlighting their expanding clinical use, underlying mechanisms and the challenges that lie ahead.

In the era of precision oncology, the integration of high-throughput, multimodal datasets presents both a formidable challenge and a transformative opportunity. We spoke to Dr. Benjamin Haibe-Kains about how AI/ML data models are helping.

Dr. Jennifer Man, director of Science at UK Biocentre, explains why biological sample storage must evolve to prevent costly research losses and meet new regulations with automated, climate-friendly systems.

Liquid biopsies offer a less invasive, yet highly informative, alternative to traditional diagnostic methods. This article examines how liquid biopsies are aiding cancer drug development and guiding treatment strategies.

Discover how next-generation sequencing is transforming diagnostics, guiding treatment decisions and shaping the future of personalized medicine.